Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 46

1.

High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant.

Komadina N, Quiñones-Parra SM, Kedzierska K, McCaw JM, Kelso A, Leder K, McVernon J.

J Med Virol. 2016 Mar 7. doi: 10.1002/jmv.24516. [Epub ahead of print]

PMID:
26950895
2.

Forecasting influenza outbreak dynamics in Melbourne from internet seach query surveillance data.

Moss R, Zarebski A, Dawson P, McCaw JM.

Influenza Other Respir Viruses. 2016 Feb 9. doi: 10.1111/irv.12376. [Epub ahead of print]

3.

Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+ T cells in aged mice.

Quinn KM, Zaloumis SG, Cukalac T, Kan WT, Sng XY, Mirams M, Watson KA, McCaw JM, Doherty PC, Thomas PG, Handel A, La Gruta NL.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1333-8. doi: 10.1073/pnas.1525167113. Epub 2016 Jan 19.

PMID:
26787864
4.

On the extinction probability in models of within-host infection: the role of latency and immunity.

Yan AW, Cao P, McCaw JM.

J Math Biol. 2016 Jan 9. [Epub ahead of print]

PMID:
26748917
5.

The effects of demographic change on disease transmission and vaccine impact in a household structured population.

Geard N, Glass K, McCaw JM, McBryde ES, Korb KB, Keeling MJ, McVernon J.

Epidemics. 2015 Dec;13:56-64. doi: 10.1016/j.epidem.2015.08.002. Epub 2015 Sep 2.

6.

Social encounter profiles of greater Melbourne residents, by location--a telephone survey.

Rolls DA, Geard NL, Warr DJ, Nathan PM, Robins GL, Pattison PE, McCaw JM, McVernon J.

BMC Infect Dis. 2015 Nov 2;15:494. doi: 10.1186/s12879-015-1237-9.

7.

Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.

Campbell PT, McCaw JM, McIntyre P, McVernon J.

Vaccine. 2015 Oct 26;33(43):5794-800. doi: 10.1016/j.vaccine.2015.09.025. Epub 2015 Sep 19.

PMID:
26392008
8.

Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.

Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL, McCaw JM.

PLoS Comput Biol. 2015 Aug 18;11(8):e1004334. doi: 10.1371/journal.pcbi.1004334. eCollection 2015 Aug.

9.

Quantifying relative within-host replication fitness in influenza virus competition experiments.

Petrie SM, Butler J, Barr IG, McVernon J, Hurt AC, McCaw JM.

J Theor Biol. 2015 Oct 7;382:259-71. doi: 10.1016/j.jtbi.2015.07.003. Epub 2015 Jul 15.

PMID:
26188087
10.

Factors associated with transmission of influenza-like illness in a cohort of households containing multiple children.

Brown CR, McCaw JM, Fairmaid EJ, Brown LE, Leder K, Sinclair M, McVernon J.

Influenza Other Respir Viruses. 2015 Sep;9(5):247-54. doi: 10.1111/irv.12331.

11.

Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.

Laurie KL, Guarnaccia TA, Carolan LA, Yan AW, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM, Barr IG.

J Infect Dis. 2015 Dec 1;212(11):1701-10. doi: 10.1093/infdis/jiv260. Epub 2015 May 5.

12.

Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance.

Dogovski C, Xie SC, Burgio G, Bridgford J, Mok S, McCaw JM, Chotivanich K, Kenny S, Gnädig N, Straimer J, Bozdech Z, Fidock DA, Simpson JA, Dondorp AM, Foote S, Klonis N, Tilley L.

PLoS Biol. 2015 Apr 22;13(4):e1002132. doi: 10.1371/journal.pbio.1002132. eCollection 2015 Apr.

13.

Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.

Bolton KJ, McCaw JM, Brown L, Jackson D, Kedzierska K, McVernon J.

PLoS One. 2015 Mar 26;10(3):e0120138. doi: 10.1371/journal.pone.0120138. eCollection 2015.

14.

Pertussis models to inform vaccine policy.

Campbell PT, McCaw JM, McVernon J.

Hum Vaccin Immunother. 2015;11(3):669-78. doi: 10.1080/21645515.2015.1011575. Review.

15.

A new approach to estimating trends in chlamydia incidence.

Ali H, Cameron E, Drovandi CC, McCaw JM, Guy RJ, Middleton M, El-Hayek C, Hocking JS, Kaldor JM, Donovan B, Wilson DP; Australian chlamydia incidence estimation group.

Sex Transm Infect. 2015 Nov;91(7):513-9. doi: 10.1136/sextrans-2014-051631. Epub 2015 Jan 6.

PMID:
25564675
16.

Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.

Zaloumis SG, Tarning J, Krishna S, Price RN, White NJ, Davis TM, McCaw JM, Olliaro P, Maude RJ, Kremsner P, Dondorp A, Gomes M, Barnes K, Simpson JA.

CPT Pharmacometrics Syst Pharmacol. 2014 Nov 5;3:e145. doi: 10.1038/psp.2014.43.

17.

Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission.

Dafilis MP, Frascoli F, McVernon J, Heffernan JM, McCaw JM.

Theor Biol Med Model. 2014 Oct 4;11:43. doi: 10.1186/1742-4682-11-43.

18.

The influence of changing host immunity on 1918-19 pandemic dynamics.

Bolton KJ, McCaw JM, McVernon J, Mathews JD.

Epidemics. 2014 Sep;8:18-27. doi: 10.1016/j.epidem.2014.07.004. Epub 2014 Aug 8.

19.

The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission.

Dafilis MP, Frascoli F, McVernon J, Heffernan JM, McCaw JM.

J Theor Biol. 2014 Nov 21;361:124-32. doi: 10.1016/j.jtbi.2014.07.028. Epub 2014 Aug 5.

PMID:
25106793
20.

Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs.

Simpson JA, Zaloumis S, DeLivera AM, Price RN, McCaw JM.

AAPS J. 2014 Sep;16(5):962-74. doi: 10.1208/s12248-014-9647-y. Epub 2014 Jul 24. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk